Literature DB >> 28386689

Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.

Sirio Cocozza1, Gaia Olivo2, Eleonora Riccio3, Camilla Russo2, Giuseppe Pontillo2, Lorenzo Ugga2, Silvia Migliaccio3, Dario de Rosa2, Sandro Feriozzi4, Massimiliano Veroux5, Yuri Battaglia6, Daniela Concolino7, Federico Pieruzzi8, Antonino Tuttolomondo9, Aurelio Caronia10, Cinzia Valeria Russo11, Roberta Lanzillo11, Vincenzo Brescia Morra11, Massimo Imbriaco2, Arturo Brunetti2, Enrico Tedeschi2, Antonio Pisani3.   

Abstract

PURPOSE: Multiple sclerosis (MS) has been proposed as a possible differential diagnosis for Fabry disease (FD). The aim of this work was to evaluate the involvement of corpus callosum (CC) on MR images and its possible role as a radiological sign to differentiate between FD and MS.
METHODS: In this multicentric study, we retrospectively evaluated the presence of white matter lesions (WMLs) on the FLAIR images of 104 patients with FD and 117 patients with MS. The incidence of CC-WML was assessed in the two groups and also in a subgroup of 37 FD patients showing neurological symptoms.
RESULTS: WMLs were detected in 50 of 104 FD patients (48.1%) and in all MS patients. However, a lesion in the CC was detected in only 3 FD patients (2.9%) and in 106 MS patients (90.6%). In the FD subgroup with neurological symptoms, WMLs were present in 26 of 37 patients (70.3%), with two subjects (5.4%) showing a definite callosal lesion.
CONCLUSION: FD patients have a very low incidence of CC involvement on conventional MR images compared to MS, independently from the clinical presentation and the overall degree of WM involvement. Evaluating the presence of CC lesions on brain MR scans can be used as a radiological sign for a differential diagnosis between MS and FD, rapidly addressing the physician toward a correct diagnosis and subsequent treatment options.

Entities:  

Keywords:  Corpus callosum; Fabry disease; MRI; Multiple sclerosis

Mesh:

Year:  2017        PMID: 28386689     DOI: 10.1007/s00234-017-1829-8

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  36 in total

1.  Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.

Authors:  J H Simon; D Li; A Traboulsee; P K Coyle; D L Arnold; F Barkhof; J A Frank; R Grossman; D W Paty; E W Radue; J S Wolinsky
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

2.  Fabry disease mimicking multiple sclerosis: Lessons from two case reports.

Authors:  S E Shribman; A R F Shah; D J Werring; O C Cockerell
Journal:  Mult Scler Relat Disord       Date:  2015-01-28       Impact factor: 4.339

3.  CNS manifestations of Fabry's disease.

Authors:  Andreas Fellgiebel; Matthias J Müller; Lionel Ginsberg
Journal:  Lancet Neurol       Date:  2006-09       Impact factor: 44.182

Review 4.  The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases.

Authors:  Nidhi Garg; Stephen W Reddel; David H Miller; Jeremy Chataway; D Sean Riminton; Yael Barnett; Lynette Masters; Michael H Barnett; Todd A Hardy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-09       Impact factor: 10.154

5.  Brain magnetic resonance imaging findings fail to suspect Fabry disease in young patients with an acute cerebrovascular event.

Authors:  Franz Fazekas; Christian Enzinger; Reinhold Schmidt; Ulrike Grittner; Anne-Katrin Giese; Michael G Hennerici; Roman Huber; Gerhard J Jungehulsing; Manfred Kaps; Christof Kessler; Peter Martus; Jukka Putaala; Stefan Ropele; Christian Tanislav; Turgut Tatlisumak; Vincent Thijs; Bettina von Sarnowski; Bo Norrving; Arndt Rolfs
Journal:  Stroke       Date:  2015-04-21       Impact factor: 7.914

6.  Fabry disease mimicking multiple sclerosis.

Authors:  Sabahattin Saip; Derya Uluduz; Gokhan Erkol
Journal:  Clin Neurol Neurosurg       Date:  2007-01-17       Impact factor: 1.876

7.  Detecting the effects of Fabry disease in the adult human brain with diffusion tensor imaging and fast bound-pool fraction imaging.

Authors:  Hunter R Underhill; Katie Golden-Grant; Lauren T Garrett; Stefanie Uhrich; Brandon A Zielinski; C Ronald Scott
Journal:  J Magn Reson Imaging       Date:  2015-05-27       Impact factor: 4.813

8.  Subcallosal striations: early findings of multiple sclerosis on sagittal, thin-section, fast FLAIR MR images.

Authors:  S Palmer; W G Bradley; D Y Chen; S Patel
Journal:  Radiology       Date:  1999-01       Impact factor: 11.105

9.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  9 in total

1.  The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease.

Authors:  Mario Tranfa; Mario Tortora; Giuseppe Pontillo; Valentina Iuzzolino; Eleonora Riccio; Simona Caccavallo; Teodolinda Di Risi; Serena Monti; Roberta Lanzillo; Vincenzo Brescia Morra; Giuseppe Palma; Maria Petracca; Antonio Pisani; Arturo Brunetti; Sirio Cocozza
Journal:  Eur Radiol       Date:  2022-01-14       Impact factor: 5.315

2.  Corpus callosum lesions are associated with worse cognitive performance in cerebral amyloid angiopathy.

Authors:  Whitney M Freeze; Maria Clara Zanon Zotin; Ashley A Scherlek; Valentina Perosa; Corinne A Auger; Andrew D Warren; Louise van der Weerd; Dorothee Schoemaker; Mitchell J Horn; M Edip Gurol; Elif Gokcal; Brian J Bacskai; Anand Viswanathan; Steven M Greenberg; Yael D Reijmer; Susanne J van Veluw
Journal:  Brain Commun       Date:  2022-04-26

Review 3.  Neuroimaging in Fabry disease: current knowledge and future directions.

Authors:  Sirio Cocozza; Camilla Russo; Giuseppe Pontillo; Antonio Pisani; Arturo Brunetti
Journal:  Insights Imaging       Date:  2018-11-02

Review 4.  Deficiency in the Screening Process of Fabry Disease: Analysis of Chronic Kidney Patients Not on Dialysis.

Authors:  Yuri Battaglia; Fulvio Fiorini; Cristiano Azzini; Pasquale Esposito; Alessandro De Vito; Antonio Granata; Alda Storari; Renzo Mignani
Journal:  Front Med (Lausanne)       Date:  2021-02-09

5.  Neuroradiological differentiation of white matter lesions in patients with multiple sclerosis and Fabry disease.

Authors:  Jakob Rath; Olivia Foesleitner; Lukas Haider; Hubert Bickel; Fritz Leutmezer; Stephan Polanec; Michael A Arnoldner; Gere Sunder-Plassmann; Daniela Prayer; Thomas Berger; Paulus Rommer; Gregor Kasprian
Journal:  Orphanet J Rare Dis       Date:  2022-02-05       Impact factor: 4.123

6.  Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A Systematic Review.

Authors:  Magdalena Mroczek; Ignazio Maniscalco; Manon Sendel; Ralf Baron; Erich Seifritz; Albina Nowak
Journal:  Front Psychiatry       Date:  2022-03-16       Impact factor: 4.157

7.  White matter hyperintensities in Burning Mouth Syndrome assessed according to the Age-Related White Matter Changes scale.

Authors:  Daniela Adamo; Federica Canfora; Elena Calabria; Noemi Coppola; Stefania Leuci; Giuseppe Pecoraro; Renato Cuocolo; Lorenzo Ugga; Luca D'Aniello; Massimo Aria; Michele D Mignogna
Journal:  Front Aging Neurosci       Date:  2022-09-01       Impact factor: 5.702

8.  Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis.

Authors:  Lorenzo Ugga; Sirio Cocozza; Giuseppe Pontillo; Camilla Russo; Vincenzo Brescia Morra; Roberta Lanzillo; Eleonora Riccio; Antonio Pisani; Arturo Brunetti
Journal:  Brain Behav       Date:  2018-10-02       Impact factor: 2.708

9.  Enzyme replacement therapy and white matter hyperintensity progression in Fabry disease.

Authors:  James D Stefaniak; Laura M Parkes; Adrian R Parry-Jones; Gillian M Potter; Andy Vail; Ana Jovanovic; Craig J Smith
Journal:  Neurology       Date:  2018-09-12       Impact factor: 9.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.